Literature DB >> 16355290

The pathophysiology of migraine: year 2005.

M Gabriella Buzzi1, Michael A Moskowitz.   

Abstract

Migraine is a complex patholophysiology in which both central and peripheral components of the trigeminal pain pathway probably play a significant role, both in the symptoms and signs of the attack and in the mechanisms of action of antimigraine compounds, such as triptans, which constitute the most important therapy for aborting migraine pain and possess several mechanisms on 5-HT receptor-mediated actions. The experimental neurogenic inflammation model represents a simple procedure to obtain preliminary information on well characterized receptortargeted drugs. The apparent paradox observed with certain drugs that are shown to be effective in this model but not in clinical trials offers the opportunity to better manipulate structure-activity to obtain the best pharmacological profile using an array of experimental models. The observation that nitric oxide donors induce migraine-like pain in migraineours and that nitric oxide plays a pivotal role in the control of several functions in the central nervous system, has prompted the use of such molecules for better understanding the pathophysiology of migraine attacks. A link between central and peripheral components of the trigeminal pain pathway is provided by the observation that cortical spreading depression in the rat activates trigeminovascular afferents and induces a series of cortical meningeal and brainstem events consistent with the development of headache. Studies in humans support the hypothesis that cortical spreading depression underlies migraine.aura. Therefore, tt is possible that visual, motor or sensory aura might be responsible for the generation of the pain through the above mechanisms.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16355290      PMCID: PMC3451639          DOI: 10.1007/s10194-005-0165-2

Source DB:  PubMed          Journal:  J Headache Pain        ISSN: 1129-2369            Impact factor:   7.277


  26 in total

Review 1.  Chemical mediators of migraine: preclinical and clinical observations.

Authors:  Saurabh Gupta; Stephanie J Nahas; B Lee Peterlin
Journal:  Headache       Date:  2011-06       Impact factor: 5.887

2.  Comparative analysis and diagnostic accuracy of the cervical flexion-rotation test.

Authors:  Toby M Hall; Kathy Briffa; Diana Hopper; Kim Robinson
Journal:  J Headache Pain       Date:  2010-05-28       Impact factor: 7.277

3.  Low unesterified:esterified eicosapentaenoic acid (EPA) plasma concentration ratio is associated with bipolar disorder episodes, and omega-3 plasma concentrations are altered by treatment.

Authors:  Erika Fh Saunders; Aubrey Reider; Gagan Singh; Alan J Gelenberg; Stanley I Rapoport
Journal:  Bipolar Disord       Date:  2015-10-01       Impact factor: 6.744

Review 4.  Patent foramen ovale and migraine: association, causation, and implications of clinical trials.

Authors:  Stewart J Tepper; Catalina Cleves; Frederick R Taylor
Journal:  Curr Pain Headache Rep       Date:  2009-06

5.  Stroke and migraine.

Authors:  Jesse Weinberger
Journal:  Curr Treat Options Cardiovasc Med       Date:  2008-06

6.  Dural neurogenic inflammation induced by neuropathic pain is specific to cranial region.

Authors:  B Filipović; I Matak; Z Lacković
Journal:  J Neural Transm (Vienna)       Date:  2013-12-24       Impact factor: 3.575

7.  Investigation of the immunoreactivities of NOS enzymes and the effect of sumatriptan in adolescent rats using an experimental model of migraine.

Authors:  Semra Hiz Kurul; Savas Demirpence; Müge Kiray; Kazim Tugyan; Osman Yilmaz; Galip Kose
Journal:  J Headache Pain       Date:  2008-08-08       Impact factor: 7.277

8.  Patent foramen ovale and migraine: a cross-sectional study from the Northern Manhattan Study (NOMAS).

Authors:  Tatjana Rundek; Mitchell S V Elkind; Marco R Di Tullio; Emmanuel Carrera; Zhezhen Jin; Ralph L Sacco; Shunichi Homma
Journal:  Circulation       Date:  2008-09-15       Impact factor: 29.690

9.  Vestibular-evoked myogenic potentials in vestibular migraine.

Authors:  Bernhard Baier; N Stieber; M Dieterich
Journal:  J Neurol       Date:  2009-04-18       Impact factor: 4.849

10.  The existence of a local 5-hydroxytryptaminergic system in peripheral arteries.

Authors:  W Ni; T J Geddes; J R C Priestley; T Szasz; D M Kuhn; S W Watts
Journal:  Br J Pharmacol       Date:  2008-04-14       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.